139 related articles for article (PubMed ID: 30158187)
1. Electrosprayed microparticles for intestinal delivery of prednisolone.
Shams T; Illangakoon UE; Parhizkar M; Harker AH; Edirisinghe S; Orlu M; Edirisinghe M
J R Soc Interface; 2018 Aug; 15(145):. PubMed ID: 30158187
[TBL] [Abstract][Full Text] [Related]
2. Engineering polymer blend microparticles: an investigation into the influence of polymer blend distribution and interaction.
Alhnan MA; Basit AW
Eur J Pharm Sci; 2011 Jan; 42(1-2):30-6. PubMed ID: 20950685
[TBL] [Abstract][Full Text] [Related]
3. A novel double-coating approach for improved pH-triggered delivery to the ileo-colonic region of the gastrointestinal tract.
Liu F; Moreno P; Basit AW
Eur J Pharm Biopharm; 2010 Feb; 74(2):311-5. PubMed ID: 19932177
[TBL] [Abstract][Full Text] [Related]
4. Extended release delivery system of metoprolol succinate using hot-melt extrusion: effect of release modifier on methacrylic acid copolymer.
Sawant KP; Fule R; Maniruzzaman M; Amin PD
Drug Deliv Transl Res; 2018 Dec; 8(6):1679-1693. PubMed ID: 29948916
[TBL] [Abstract][Full Text] [Related]
5. A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation Of drug release using Eudragit L100-55 and Eudragit S100 combinations.
Khan MZ; Prebeg Z; Kurjaković N
J Control Release; 1999 Mar; 58(2):215-22. PubMed ID: 10053194
[TBL] [Abstract][Full Text] [Related]
6. Influence of lidocaine forms (salt vs. freebase) on properties of drug-eudragit® L100-55 extrudates prepared by reactive melt extrusion.
Liu X; Ma X; Kun E; Guo X; Yu Z; Zhang F
Int J Pharm; 2018 Aug; 547(1-2):291-302. PubMed ID: 29883791
[TBL] [Abstract][Full Text] [Related]
7. Development of enteric-coated fixed dose combinations of amorphous solid dispersions of ezetimibe and lovastatin: Investigation of formulation and process parameters.
Riekes MK; Dereymaker A; Berben P; Augustijns P; Stulzer HK; Van den Mooter G
Int J Pharm; 2017 Mar; 520(1-2):49-58. PubMed ID: 28153650
[TBL] [Abstract][Full Text] [Related]
8. Mucoadhesive platforms for targeted delivery to the colon.
Varum FJ; Veiga F; Sousa JS; Basit AW
Int J Pharm; 2011 Nov; 420(1):11-9. PubMed ID: 21856393
[TBL] [Abstract][Full Text] [Related]
9. Fabrication and in vivo evaluation of highly pH-responsive acrylic microparticles for targeted gastrointestinal delivery.
Kendall RA; Alhnan MA; Nilkumhang S; Murdan S; Basit AW
Eur J Pharm Sci; 2009 Jun; 37(3-4):284-90. PubMed ID: 19491017
[TBL] [Abstract][Full Text] [Related]
10. Comparison of simple Eudragit microparticles loaded with prednisolone and Eudragit-coated chitosan-succinyl-prednisolone conjugate microparticles: Part I. Particle characteristics and in vitro evaluation as a colonic delivery system.
Onishi H; Kikuchi H; Machida Y
Drug Dev Ind Pharm; 2012 Jul; 38(7):800-7. PubMed ID: 22077373
[TBL] [Abstract][Full Text] [Related]
11. Preparation and in vitro release of zein microparticles loaded with prednisolone for oral delivery.
Lau ET; Johnson SK; Mikkelsen D; Halley PJ; Steadman KJ
J Microencapsul; 2012; 29(7):706-12. PubMed ID: 22612552
[TBL] [Abstract][Full Text] [Related]
12. Eudragit RS 100 microparticles containing 2-hydroxypropyl-beta-cyclodextrin and glutathione: physicochemical characterization, drug release and transport studies.
Trapani A; Laquintana V; Denora N; Lopedota A; Cutrignelli A; Franco M; Trapani G; Liso G
Eur J Pharm Sci; 2007 Jan; 30(1):64-74. PubMed ID: 17118631
[TBL] [Abstract][Full Text] [Related]
13. Studies of chitosan/organic acid/Eudragit RS/RL-coated system for colonic delivery.
Kaur K; Kim K
Int J Pharm; 2009 Jan; 366(1-2):140-8. PubMed ID: 18835342
[TBL] [Abstract][Full Text] [Related]
14. Spray-dried Eudragit® L100 microparticles containing ferulic acid: Formulation, in vitro cytoprotection and in vivo anti-platelet effect.
Nadal JM; Gomes MLS; Borsato DM; Almeida MA; Barboza FM; Zawadzki SF; Kanunfre CC; Farago PV; Zanin SMW
Mater Sci Eng C Mater Biol Appl; 2016 Jul; 64():318-328. PubMed ID: 27127059
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of interpolyelectrolyte complexes of chitosan with Eudragit L100 and Eudragit L100-55 as potential carriers for oral controlled drug delivery.
Moustafine RI; Margulis EB; Sibgatullina LF; Kemenova VA; Van den Mooter G
Eur J Pharm Biopharm; 2008 Sep; 70(1):215-25. PubMed ID: 18691856
[TBL] [Abstract][Full Text] [Related]
16. Colonic delivery of indometacin loaded PGA-co-PDL microparticles coated with Eudragit L100-55 from fast disintegrating tablets.
Tawfeek HM; Abdellatif AAH; Dennison TJ; Mohammed AR; Sadiq Y; Saleem IY
Int J Pharm; 2017 Oct; 531(1):80-89. PubMed ID: 28818458
[TBL] [Abstract][Full Text] [Related]
17. Design, statistical optimisation, characterisation and pharmacodynamic studies on Pioglitazone hydrochloride floating microparticles.
Rao BP; Baby B; Mathews R; Rajarajan S; Haritha P; Ramesh K; Gupta NV
J Microencapsul; 2014; 31(4):406-14. PubMed ID: 24697182
[TBL] [Abstract][Full Text] [Related]
18. Morphological and physicochemical evaluation of the propranolol HCl-Eudragit
Garjani A; Barzegar-Jalali M; Osouli-Bostanabad K; Ranjbar H; Adibkia K
Artif Cells Nanomed Biotechnol; 2018 Jun; 46(4):749-756. PubMed ID: 28587486
[TBL] [Abstract][Full Text] [Related]
19. Preparation of microparticles of naproxen with Eudragit RS and talc by spherical crystallization technique.
Maghsoodi M; Esfahani M
Pharm Dev Technol; 2009; 14(4):442-50. PubMed ID: 19235551
[TBL] [Abstract][Full Text] [Related]
20. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
